Global Radiopharmaceuticals Market Research Report 2023

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Highlights

The global Radiopharmaceuticals market was valued at US$ 6761 million in 2022 and is anticipated to reach US$ 11660 million by 2029, witnessing a CAGR of 8.0% during the forecast period 2023-2029.

The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Radiopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceuticals.

The Radiopharmaceuticals market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Radiopharmaceuticals market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Radiopharmaceuticals manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Diagnostic Radioisotopes

Therapeutic Radioisotopes

Oncology

Cardiology

Other

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Radiopharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

1.1 Product Overview and Scope of Radiopharmaceuticals

1.2 Radiopharmaceuticals Segment by Type

1.2.1 Global Radiopharmaceuticals Market Value Comparison by Type (2023-2029)

1.2.2 Diagnostic Radioisotopes

1.2.3 Therapeutic Radioisotopes

1.3 Radiopharmaceuticals Segment by Application

1.3.1 Global Radiopharmaceuticals Market Value by Application: (2023-2029)

1.3.2 Oncology

1.3.3 Cardiology

1.3.4 Other

1.4 Global Radiopharmaceuticals Market Size Estimates and Forecasts

1.4.1 Global Radiopharmaceuticals Revenue 2018-2029

1.4.2 Global Radiopharmaceuticals Sales 2018-2029

1.4.3 Global Radiopharmaceuticals Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Radiopharmaceuticals Sales Market Share by Manufacturers (2018-2023)

2.2 Global Radiopharmaceuticals Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Radiopharmaceuticals Average Price by Manufacturers (2018-2023)

2.4 Global Radiopharmaceuticals Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Radiopharmaceuticals, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Radiopharmaceuticals, Product Type & Application

2.7 Radiopharmaceuticals Market Competitive Situation and Trends

2.7.1 Radiopharmaceuticals Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Radiopharmaceuticals Players Market Share by Revenue

2.7.3 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Radiopharmaceuticals Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Radiopharmaceuticals Global Radiopharmaceuticals Sales by Region: 2018-2029

3.2.1 Global Radiopharmaceuticals Sales by Region: 2018-2023

3.2.2 Global Radiopharmaceuticals Sales by Region: 2024-2029

3.3 Global Radiopharmaceuticals Global Radiopharmaceuticals Revenue by Region: 2018-2029

3.3.1 Global Radiopharmaceuticals Revenue by Region: 2018-2023

3.3.2 Global Radiopharmaceuticals Revenue by Region: 2024-2029

3.4 North America Radiopharmaceuticals Market Facts & Figures by Country

3.4.1 North America Radiopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Radiopharmaceuticals Sales by Country (2018-2029)

3.4.3 North America Radiopharmaceuticals Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Radiopharmaceuticals Market Facts & Figures by Country

3.5.1 Europe Radiopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Radiopharmaceuticals Sales by Country (2018-2029)

3.5.3 Europe Radiopharmaceuticals Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Radiopharmaceuticals Market Facts & Figures by Country

3.6.1 Asia Pacific Radiopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Radiopharmaceuticals Sales by Country (2018-2029)

3.6.3 Asia Pacific Radiopharmaceuticals Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Radiopharmaceuticals Market Facts & Figures by Country

3.7.1 Latin America Radiopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Radiopharmaceuticals Sales by Country (2018-2029)

3.7.3 Latin America Radiopharmaceuticals Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Radiopharmaceuticals Market Facts & Figures by Country

3.8.1 Middle East and Africa Radiopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Radiopharmaceuticals Sales by Country (2018-2029)

3.8.3 Middle East and Africa Radiopharmaceuticals Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Radiopharmaceuticals Sales by Type (2018-2029)

4.1.1 Global Radiopharmaceuticals Sales by Type (2018-2023)

4.1.2 Global Radiopharmaceuticals Sales by Type (2024-2029)

4.1.3 Global Radiopharmaceuticals Sales Market Share by Type (2018-2029)

4.2 Global Radiopharmaceuticals Revenue by Type (2018-2029)

4.2.1 Global Radiopharmaceuticals Revenue by Type (2018-2023)

4.2.2 Global Radiopharmaceuticals Revenue by Type (2024-2029)

4.2.3 Global Radiopharmaceuticals Revenue Market Share by Type (2018-2029)

4.3 Global Radiopharmaceuticals Price by Type (2018-2029)

5.1 Global Radiopharmaceuticals Sales by Application (2018-2029)

5.1.1 Global Radiopharmaceuticals Sales by Application (2018-2023)

5.1.2 Global Radiopharmaceuticals Sales by Application (2024-2029)

5.1.3 Global Radiopharmaceuticals Sales Market Share by Application (2018-2029)

5.2 Global Radiopharmaceuticals Revenue by Application (2018-2029)

5.2.1 Global Radiopharmaceuticals Revenue by Application (2018-2023)

5.2.2 Global Radiopharmaceuticals Revenue by Application (2024-2029)

5.2.3 Global Radiopharmaceuticals Revenue Market Share by Application (2018-2029)

5.3 Global Radiopharmaceuticals Price by Application (2018-2029)

6.1 Bracco Imaging

6.1.1 Bracco Imaging Corporation Information

6.1.2 Bracco Imaging Description and Business Overview

6.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Bracco Imaging Radiopharmaceuticals Product Portfolio

6.1.5 Bracco Imaging Recent Developments/Updates

6.2 Bayer

6.2.1 Bayer Corporation Information

6.2.2 Bayer Description and Business Overview

6.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Bayer Radiopharmaceuticals Product Portfolio

6.2.5 Bayer Recent Developments/Updates

6.3 Mallinckrodt

6.3.1 Mallinckrodt Corporation Information

6.3.2 Mallinckrodt Description and Business Overview

6.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Mallinckrodt Radiopharmaceuticals Product Portfolio

6.3.5 Mallinckrodt Recent Developments/Updates

6.4 Nordion

6.4.1 Nordion Corporation Information

6.4.2 Nordion Description and Business Overview

6.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Nordion Radiopharmaceuticals Product Portfolio

6.4.5 Nordion Recent Developments/Updates

6.5 Triad Isotopes

6.5.1 Triad Isotopes Corporation Information

6.5.2 Triad Isotopes Description and Business Overview

6.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Triad Isotopes Radiopharmaceuticals Product Portfolio

6.5.5 Triad Isotopes Recent Developments/Updates

6.6 Lantheus

6.6.1 Lantheus Corporation Information

6.6.2 Lantheus Description and Business Overview

6.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Lantheus Radiopharmaceuticals Product Portfolio

6.6.5 Lantheus Recent Developments/Updates

6.7 IBA Group

6.6.1 IBA Group Corporation Information

6.6.2 IBA Group Description and Business Overview

6.6.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.4.4 IBA Group Radiopharmaceuticals Product Portfolio

6.7.5 IBA Group Recent Developments/Updates

6.8 GE Healthcare

6.8.1 GE Healthcare Corporation Information

6.8.2 GE Healthcare Description and Business Overview

6.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.8.4 GE Healthcare Radiopharmaceuticals Product Portfolio

6.8.5 GE Healthcare Recent Developments/Updates

6.9 China Isotope & Radiation

6.9.1 China Isotope & Radiation Corporation Information

6.9.2 China Isotope & Radiation Description and Business Overview

6.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.9.4 China Isotope & Radiation Radiopharmaceuticals Product Portfolio

6.9.5 China Isotope & Radiation Recent Developments/Updates

6.10 Jubilant Pharma

6.10.1 Jubilant Pharma Corporation Information

6.10.2 Jubilant Pharma Description and Business Overview

6.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Jubilant Pharma Radiopharmaceuticals Product Portfolio

6.10.5 Jubilant Pharma Recent Developments/Updates

6.11 Eli Lilly

6.11.1 Eli Lilly Corporation Information

6.11.2 Eli Lilly Radiopharmaceuticals Description and Business Overview

6.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Eli Lilly Radiopharmaceuticals Product Portfolio

6.11.5 Eli Lilly Recent Developments/Updates

6.12 Advanced Accelerator Applications

6.12.1 Advanced Accelerator Applications Corporation Information

6.12.2 Advanced Accelerator Applications Radiopharmaceuticals Description and Business Overview

6.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio

6.12.5 Advanced Accelerator Applications Recent Developments/Updates

6.13 SIEMENS

6.13.1 SIEMENS Corporation Information

6.13.2 SIEMENS Radiopharmaceuticals Description and Business Overview

6.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.13.4 SIEMENS Radiopharmaceuticals Product Portfolio

6.13.5 SIEMENS Recent Developments/Updates

6.14 Dongcheng

6.14.1 Dongcheng Corporation Information

6.14.2 Dongcheng Radiopharmaceuticals Description and Business Overview

6.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Dongcheng Radiopharmaceuticals Product Portfolio

6.14.5 Dongcheng Recent Developments/Updates

6.15 Navidea

6.15.1 Navidea Corporation Information

6.15.2 Navidea Radiopharmaceuticals Description and Business Overview

6.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Navidea Radiopharmaceuticals Product Portfolio

6.15.5 Navidea Recent Developments/Updates

7.1 Radiopharmaceuticals Industry Chain Analysis

7.2 Radiopharmaceuticals Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Radiopharmaceuticals Production Mode & Process

7.4 Radiopharmaceuticals Sales and Marketing

7.4.1 Radiopharmaceuticals Sales Channels

7.4.2 Radiopharmaceuticals Distributors

7.5 Radiopharmaceuticals Customers

8.1 Radiopharmaceuticals Industry Trends

8.2 Radiopharmaceuticals Market Drivers

8.3 Radiopharmaceuticals Market Challenges

8.4 Radiopharmaceuticals Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Radiopharmaceuticals Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Radiopharmaceuticals Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Radiopharmaceuticals Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Radiopharmaceuticals Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Radiopharmaceuticals Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Radiopharmaceuticals Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Radiopharmaceuticals Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Radiopharmaceuticals Average Price (USD/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Radiopharmaceuticals, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Radiopharmaceuticals, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Radiopharmaceuticals, Product Type & Application

    Table 12. Global Key Manufacturers of Radiopharmaceuticals, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Radiopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)

    Table 18. Global Radiopharmaceuticals Sales Market Share by Region (2018-2023)

    Table 19. Global Radiopharmaceuticals Sales by Region (2024-2029) & (K Units)

    Table 20. Global Radiopharmaceuticals Sales Market Share by Region (2024-2029)

    Table 21. Global Radiopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Radiopharmaceuticals Revenue Market Share by Region (2018-2023)

    Table 23. Global Radiopharmaceuticals Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Radiopharmaceuticals Revenue Market Share by Region (2024-2029)

    Table 25. North America Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)

    Table 27. North America Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)

    Table 28. North America Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Radiopharmaceuticals Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Radiopharmaceuticals Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Radiopharmaceuticals Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Radiopharmaceuticals Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Radiopharmaceuticals Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Radiopharmaceuticals Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Radiopharmaceuticals Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Radiopharmaceuticals Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Radiopharmaceuticals Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Radiopharmaceuticals Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Radiopharmaceuticals Sales (K Units) by Type (2018-2023)

    Table 51. Global Radiopharmaceuticals Sales (K Units) by Type (2024-2029)

    Table 52. Global Radiopharmaceuticals Sales Market Share by Type (2018-2023)

    Table 53. Global Radiopharmaceuticals Sales Market Share by Type (2024-2029)

    Table 54. Global Radiopharmaceuticals Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Radiopharmaceuticals Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Radiopharmaceuticals Revenue Market Share by Type (2018-2023)

    Table 57. Global Radiopharmaceuticals Revenue Market Share by Type (2024-2029)

    Table 58. Global Radiopharmaceuticals Price (USD/Unit) by Type (2018-2023)

    Table 59. Global Radiopharmaceuticals Price (USD/Unit) by Type (2024-2029)

    Table 60. Global Radiopharmaceuticals Sales (K Units) by Application (2018-2023)

    Table 61. Global Radiopharmaceuticals Sales (K Units) by Application (2024-2029)

    Table 62. Global Radiopharmaceuticals Sales Market Share by Application (2018-2023)

    Table 63. Global Radiopharmaceuticals Sales Market Share by Application (2024-2029)

    Table 64. Global Radiopharmaceuticals Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Radiopharmaceuticals Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Radiopharmaceuticals Revenue Market Share by Application (2018-2023)

    Table 67. Global Radiopharmaceuticals Revenue Market Share by Application (2024-2029)

    Table 68. Global Radiopharmaceuticals Price (USD/Unit) by Application (2018-2023)

    Table 69. Global Radiopharmaceuticals Price (USD/Unit) by Application (2024-2029)

    Table 70. Bracco Imaging Corporation Information

    Table 71. Bracco Imaging Description and Business Overview

    Table 72. Bracco Imaging Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 73. Bracco Imaging Radiopharmaceuticals Product

    Table 74. Bracco Imaging Recent Developments/Updates

    Table 75. Bayer Corporation Information

    Table 76. Bayer Description and Business Overview

    Table 77. Bayer Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 78. Bayer Radiopharmaceuticals Product

    Table 79. Bayer Recent Developments/Updates

    Table 80. Mallinckrodt Corporation Information

    Table 81. Mallinckrodt Description and Business Overview

    Table 82. Mallinckrodt Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 83. Mallinckrodt Radiopharmaceuticals Product

    Table 84. Mallinckrodt Recent Developments/Updates

    Table 85. Nordion Corporation Information

    Table 86. Nordion Description and Business Overview

    Table 87. Nordion Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 88. Nordion Radiopharmaceuticals Product

    Table 89. Nordion Recent Developments/Updates

    Table 90. Triad Isotopes Corporation Information

    Table 91. Triad Isotopes Description and Business Overview

    Table 92. Triad Isotopes Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 93. Triad Isotopes Radiopharmaceuticals Product

    Table 94. Triad Isotopes Recent Developments/Updates

    Table 95. Lantheus Corporation Information

    Table 96. Lantheus Description and Business Overview

    Table 97. Lantheus Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 98. Lantheus Radiopharmaceuticals Product

    Table 99. Lantheus Recent Developments/Updates

    Table 100. IBA Group Corporation Information

    Table 101. IBA Group Description and Business Overview

    Table 102. IBA Group Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 103. IBA Group Radiopharmaceuticals Product

    Table 104. IBA Group Recent Developments/Updates

    Table 105. GE Healthcare Corporation Information

    Table 106. GE Healthcare Description and Business Overview

    Table 107. GE Healthcare Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 108. GE Healthcare Radiopharmaceuticals Product

    Table 109. GE Healthcare Recent Developments/Updates

    Table 110. China Isotope & Radiation Corporation Information

    Table 111. China Isotope & Radiation Description and Business Overview

    Table 112. China Isotope & Radiation Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 113. China Isotope & Radiation Radiopharmaceuticals Product

    Table 114. China Isotope & Radiation Recent Developments/Updates

    Table 115. Jubilant Pharma Corporation Information

    Table 116. Jubilant Pharma Description and Business Overview

    Table 117. Jubilant Pharma Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 118. Jubilant Pharma Radiopharmaceuticals Product

    Table 119. Jubilant Pharma Recent Developments/Updates

    Table 120. Eli Lilly Corporation Information

    Table 121. Eli Lilly Description and Business Overview

    Table 122. Eli Lilly Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 123. Eli Lilly Radiopharmaceuticals Product

    Table 124. Eli Lilly Recent Developments/Updates

    Table 125. Advanced Accelerator Applications Corporation Information

    Table 126. Advanced Accelerator Applications Description and Business Overview

    Table 127. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 128. Advanced Accelerator Applications Radiopharmaceuticals Product

    Table 129. Advanced Accelerator Applications Recent Developments/Updates

    Table 130. SIEMENS Corporation Information

    Table 131. SIEMENS Description and Business Overview

    Table 132. SIEMENS Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 133. SIEMENS Radiopharmaceuticals Product

    Table 134. SIEMENS Recent Developments/Updates

    Table 135. Dongcheng Corporation Information

    Table 136. Dongcheng Description and Business Overview

    Table 137. Dongcheng Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 138. Dongcheng Radiopharmaceuticals Product

    Table 139. Dongcheng Recent Developments/Updates

    Table 140. Navidea Corporation Information

    Table 141. Navidea Description and Business Overview

    Table 142. Navidea Radiopharmaceuticals Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)

    Table 143. Navidea Radiopharmaceuticals Product

    Table 144. Navidea Recent Developments/Updates

    Table 145. Key Raw Materials Lists

    Table 146. Raw Materials Key Suppliers Lists

    Table 147. Radiopharmaceuticals Distributors List

    Table 148. Radiopharmaceuticals Customers List

    Table 149. Radiopharmaceuticals Market Trends

    Table 150. Radiopharmaceuticals Market Drivers

    Table 151. Radiopharmaceuticals Market Challenges

    Table 152. Radiopharmaceuticals Market Restraints

    Table 153. Research Programs/Design for This Report

    Table 154. Key Data Information from Secondary Sources

    Table 155. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Radiopharmaceuticals

    Figure 2. Global Radiopharmaceuticals Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Radiopharmaceuticals Market Share by Type in 2022 & 2029

    Figure 4. Diagnostic Radioisotopes Product Picture

    Figure 5. Therapeutic Radioisotopes Product Picture

    Figure 6. Global Radiopharmaceuticals Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Radiopharmaceuticals Market Share by Application in 2022 & 2029

    Figure 8. Oncology

    Figure 9. Cardiology

    Figure 10. Other

    Figure 11. Global Radiopharmaceuticals Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Radiopharmaceuticals Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Radiopharmaceuticals Sales (2018-2029) & (K Units)

    Figure 14. Global Radiopharmaceuticals Average Price (USD/Unit) & (2018-2029)

    Figure 15. Radiopharmaceuticals Report Years Considered

    Figure 16. Radiopharmaceuticals Sales Share by Manufacturers in 2022

    Figure 17. Global Radiopharmaceuticals Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Radiopharmaceuticals Players: Market Share by Revenue in 2022

    Figure 19. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Radiopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Radiopharmaceuticals Sales Market Share by Country (2018-2029)

    Figure 22. North America Radiopharmaceuticals Revenue Market Share by Country (2018-2029)

    Figure 23. U.S. Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Europe Radiopharmaceuticals Sales Market Share by Country (2018-2029)

    Figure 26. Europe Radiopharmaceuticals Revenue Market Share by Country (2018-2029)

    Figure 27. Germany Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. France Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. U.K. Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Italy Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Russia Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Asia Pacific Radiopharmaceuticals Sales Market Share by Region (2018-2029)

    Figure 33. Asia Pacific Radiopharmaceuticals Revenue Market Share by Region (2018-2029)

    Figure 34. China Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Japan Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. South Korea Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. India Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Australia Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. China Taiwan Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Indonesia Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Thailand Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Malaysia Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Latin America Radiopharmaceuticals Sales Market Share by Country (2018-2029)

    Figure 44. Latin America Radiopharmaceuticals Revenue Market Share by Country (2018-2029)

    Figure 45. Mexico Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Brazil Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Argentina Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa Radiopharmaceuticals Sales Market Share by Country (2018-2029)

    Figure 49. Middle East & Africa Radiopharmaceuticals Revenue Market Share by Country (2018-2029)

    Figure 50. Turkey Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Saudi Arabia Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. UAE Radiopharmaceuticals Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Global Sales Market Share of Radiopharmaceuticals by Type (2018-2029)

    Figure 54. Global Revenue Market Share of Radiopharmaceuticals by Type (2018-2029)

    Figure 55. Global Radiopharmaceuticals Price (USD/Unit) by Type (2018-2029)

    Figure 56. Global Sales Market Share of Radiopharmaceuticals by Application (2018-2029)

    Figure 57. Global Revenue Market Share of Radiopharmaceuticals by Application (2018-2029)

    Figure 58. Global Radiopharmaceuticals Price (USD/Unit) by Application (2018-2029)

    Figure 59. Radiopharmaceuticals Value Chain

    Figure 60. Radiopharmaceuticals Production Process

    Figure 61. Channels of Distribution (Direct Vs Distribution)

    Figure 62. Distributors Profiles

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed